首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1767714

抗瘧疾藥市場按藥物類別、給藥途徑、分銷管道和地區分類

Anti-malarial Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, and By Region

出版日期: 2025年06月12日 | 出版商:

Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

抗瘧疾藥市場規模預計在 2025 年達到 10.812 億美元，預計到 2032 年將達到 14.714 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 4.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	10.812億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	4.50%	2032年價值預測	14.714億美元

瘧疾原蟲，是造成廣泛感染疾病的原因。這種寄生蟲會透過被感染的雌性瘧蚊叮咬進入人體，並傳播到肝臟並在那裡產生寄生蟲。人類瘧疾通常由五種原生動物寄生蟲引起：惡性瘧原蟲、三日瘧原蟲、卵形瘧原蟲、間日瘧原蟲和諾氏瘧原蟲。這些寄生蟲中最危險的是瘧疾原蟲和瘧疾原蟲，它們是造成瘧疾死亡的主要原因。抗瘧疾藥用於治療和預防瘧疾感染。大多數抗瘧疾藥針對瘧疾感染的紅血球期，即導致症狀性疾病的感染期。早期診斷和有效治療是控制瘧疾的關鍵措施。治療瘧疾的藥物種類繁多，包括奎寧、Chloroquine、甲氟喹、氯胍和伯氨喹。此外，乙胺嘧啶和磺胺多辛、蒿甲醚和盧米凡特林等複方藥物也常用於治療瘧疾。

市場動態

瘧疾治療的研發活動正在興起，預計這將在預測期內推動市場成長。此外，各種瘧疾治療藥物正在進行臨床試驗，預計這也將在預測期內推動市場成長。此外，各藥廠正積極參與研發活動，以開發用於治療瘧疾的新型藥物。例如，2022 年 11 月，跨國製藥公司諾華公司和抗瘧藥物研發領域的產品開發夥伴關係組織「瘧疾抗瘧疾藥研發基金」（MMV）宣布，他們決定進入一種新型非青蒿素組合藥物的 3 期試驗，該藥物用於治療併發症瘧疾。這種新型組合藥物是盧米凡特林的最佳化配方，可以每天服用一次，而不是通常的每天兩次。全球正在出現對現有瘧疾治療藥物的抗藥性，需要新的藥物來繼續根除瘧疾的鬥爭。

本研究的主要特點

本報告對全球抗瘧疾藥市場進行了詳細分析，並以 2024 年為基準年，給出了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
它還強調了不同領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，對全球抗瘧疾藥市場的主要企業進行分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球抗瘧疾藥市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球抗瘧疾藥市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1,081.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.50%	2032 Value Projection:	USD 1,471.4 Mn

Plasmodium parasites, a protozoan parasite, are the cause of the widespread infectious disease malaria. A parasite enters the body through the bite of an infected female Anopheles mosquito, which then travels to the liver, where the parasite is produced. Human malaria are generally caused by five types of plasmodium parasites, including P. falciparum, P. malariae, P. ovale, P. vivax, and P.knowlesi. The most dangerous parasite species among these are P. falciparum and P. vivax, which are also the ones responsible for the majority of malaria deaths. Antimalarial drugs are used for the treatment and prevention of malaria infection. Most antimalarial drugs target the erythrocytic stage of malaria infection, which is the phase of infection that causes symptomatic illness. Early diagnosis and efficient treatment are crucial measures to control malaria. Different types of drugs such as quinine, chloroquine, mefloquine, proguanil, primaquine, and others are used in the treatment of malaria. Moreover, some combination drugs such as Pyrimethamine & sulfadoxine, Artemether & lumefantrine, and others are also prescribed for treating the disease.

Market Dynamics

The ongoing research and development for malarial treatment is expected to fuel growth of the market in the forecast period. Various drugs are undergoing the clinical trial for the malarial treatment, which is also expected to drive the market during the forecast period. Moreover, various pharmaceutical companies are actively participating in research and development activities, in order to develop novel drug entity for treatment of malaria. For instance, in November 2022, Novartis AG, a multinational pharmaceutical corporation and Medicines for Malaria Venture (MMV), a product development partnership in the field of antimalarial drug research and development announced decision to move to Phase 3 study for novel non-artemisinin combination to treat uncomplicated malaria. This novel combination also contains an optimized formulation of lumefantrine, which allows it to be given once daily versus the usual twice-daily administration. As the world faces emerging resistance to current malaria treatments, new medicines are needed to continue the fight toward elimination.

Key features of the study:

This report provides in-depth analysis of the global anti-malarial drugs market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti-malarial drugs market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Ipca Laboratories Ltd., Zydus Group, Merck KGaA, Pfizer Inc., GSK plc., Cipla Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Alvizia Health Care, Bayer AG, and F. Hoffmann-La Roche Ltd.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global anti-malarial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-malarial drugs market

Detailed Segmentation:

Global Anti-malarial Drugs Market, By Drug Class:
- Aminoquinolines
- Quinoline-methanol (4-quinolinemethanols)
- Cinchona Alkaloids
- Biguanides
- Sulfonamides and sulfones
- Others
Global Anti-malarial Drugs Market By Route of Administration:
- Oral
- Injectable
Global Anti-malarial Drugs Market By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anti-malarial Drugs Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Ipca Laboratories Ltd.
- Zydus Group
- Merck KGaA
- Pfizer Inc.
- GSK plc.
- Cipla Inc.
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Alvizia Health Care
- Bayer AG
- Hoffmann-La Roche Ltd

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Anti-malarial Drugs Market, By Drug Class, 2020-2032 (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Aminoquinolines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Quinoline-methanol (4-quinolinemethanols)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Cinchona Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Biguanides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Sulfonamides and sulfones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

5. Global Anti-malarial Drugs Market, By Route of Administration, 2020-2032 (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Anti-malarial Drugs Market, By Distribution Channel, 2020-2032 (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Anti-malarial Drugs Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032(%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
North America
- Market Size and Forecast, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, 2020-2032, (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- Ipca Laboratories Ltd.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Zydus Group
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck KGaA
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GSK plc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cipla Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novartis AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Alvizia Health Care
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bayer AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- F. Hoffmann-La Roche Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

抗瘧藥物市場－全球產業規模、佔有率、趨勢、機會及預測（按藥物類型、瘧疾類型、地區和競爭情況分類，2020-2030 年）

抗瘧疾藥市場預測至 2030 年：按藥物類型、藥物類別、瘧疾類型、給藥方式、分銷管道、最終用戶和地區進行的全球分析

抗瘧疾藥市場：按藥物類別、按藥物類型、按給藥途徑、按瘧疾類型、按配銷通路、按最終用戶 - 2025-2030 年全球預測

青蒿素抗瘧藥市場、機會、成長動力、產業趨勢分析與預測，2024-2032

FAQ

抗瘧疾藥市場按藥物類別、給藥途徑、分銷管道和地區分類